In recent years, the global pharma supply chain has been forced to change its priorities. In the face of escalating geopolitical tensions, international regulatory complexity and efforts to reduce dependency on concentrated manufacturing hubs, cost efficiency is no longer driving things forward. Instead, the sector must balance resilience, compliance, geopolitical risk and operational continuity, which demands fundamentally new approaches to sourcing, manufacturing and supplier relationships.
Events like CPHI Milan offer the industry a chance to discuss these challenges and collaborate to find solutions that will futureproof the pharma supply chain. From creating new strategies for supply chain resilience, forming diversified manufacturing partnerships and seeking regulatory expertise, here are the key issues we’re expecting to dominate the supply chain conversations at this year’s show.


